Showing results (611-620 of 833) with videos related to

Sort By:
Pageof 84
Antiviral Therapy|August 6, 2011
Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study, Lars Peters, Jacqueline Neuhaus, et al.
Plos One|May 13, 2016
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral TherapyBirgit Grund, Jason V Baker, Steven G Deeks, et al.
The American Journal of Cardiology|October 16, 2012
Electrocardiographic spatial QRS-T angle and incident cardiovascular disease in HIV-infected patients (from the Strategies for the Management of Antiretroviral Therapy [SMART] study)Farah Z Dawood, Faraaz Khan, Mollie P Roediger, et al.
AIDS (London, England)|April 28, 2011
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA studyJean-Paul Viard, Jean-Claude Souberbielle, Ole Kirk, et al.
The New England Journal of Medicine|February 24, 2001
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study GroupsB Ledergerber, A Mocroft, P Reiss, et al.
Tuberculosis Research and Treatment|May 13, 2020
Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017Marie Helleberg, Daniel Cho, Christina Ekenberg, et al.
Antiviral Therapy|September 28, 2012
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppressionAmanda Mocroft, Wendy P Bannister, Ole Kirk, et al.
AIDS (London, England)|August 16, 2013
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkersÁlvaro H Borges, Michael J Silverberg, Deborah Wentworth, et al.
HIV Medicine|February 26, 2015
Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialS Sharma, A G Babiker, S Emery, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across EuropeWendy P Bannister, Ole Kirk, Jose M Gatell, et al.
Pageof 84